(Press-News.org) Istanbul, 1 July 2012: The number of babies born as a result of assisted reproduction technologies (ART) has reached an estimated total of 5 million since the world's first, Louise Brown, was born in July 1978. The figures will be presented this week at the 28th annual meeting of ESHRE (European Society of Human Reproduction and Embryology), which begins today, 1st July, in Istanbul, Turkey.
The calculation was made for a presentation at the congress from ICMART (International Committee for Monitoring Assisted Reproductive Technologies) and was based on the number of IVF and ICSI treatment cycles recorded worldwide up to 2008 with estimations added for the following three years. The cumulative total of births was put at 4.6 million last year, and this year has now reached an approximate total of 5 million.
Commenting on this remarkable milestone, Dr David Adamson, from Fertility Physicians of Northern California, USA, and Chairman of ICMART, said: "It means that this technology has been highly successful in treating infertile patients. Millions of families with children have been created, thereby reducing the burden of infertility.
"The technology has improved greatly over the years to increase pregnancy rates. The babies are as healthy as those from other infertile patients who conceive spontaneously. The technology is available globally in many different cultures. The major barriers to access are economic, and societal in some situations. With these accomplishments as a technology, and with recognition of Professor Robert Edwards as a Nobel Laureate, IVF is firmly established now in the mainstream of medicine."
Other ICMART data indicate that around 1.5 million ART cycles are now performed globally each year, producing around 350,000 babies. This number continues to rise. The two most active countries of the world are the USA and Japan, but the most active region by far is Europe.
The picture in Europe
The latest European data to be presented at the ESHRE congress are for 2009, and show that demand for treatment - as expressed in treatment cycles performed in European countries - continues to grow, from 532,260 in 2008 to 537,287 in 2009.
The average availability of ART in Europe is close to 1000 cycles/million inhabitants, but this figure varies greatly between countries and is largely dependent on local state funding policies. Availability in Europe is greater than in the USA but less than in Australia.
Dr Anna Pia Ferraretti, chairman of ESHRE's IVF Monitoring Consortium, said that the global need for ART is estimated to be at least 1500 cycles/million population per year, a figure only seen in Denmark (2726 cycles/million), Belgium (2562 cycles), Czech Republic (1851 cycles), Slovenia (1840 cycles), Sweden (1800 cycles), Finland (1701 cycles) and Norway (1780 cycles). Countries with much lower availability included Austria (747 cycles/million), Germany (830 cycles), Italy (863 cycles) and UK (879 cycles).
Success rates from a single "fresh" treatment cycle of IVF and ICSI - as first indicated in data for 2008 presented last year - seem to have stabilised, at around 32% pregnancy rate per embryo transfer (and 28% per aspiration). Dr Ferraretti said there had been a notable decline in the number of embryos transferred, with cumulative delivery rates, which include the transfer of frozen/thawed embryos from the same stimulation cycle, now representing "the best indicator of outcome". By using this endpoint, she explained, delivery rates can increase substantially while maintaining a very low multiple rate.
On this contentious question of multiple pregnancies, Dr Ferraretti said: "The overall trend in Europe of transferring fewer embryos continues. We found in 2009 that, compared with previous years, fewer three-embryo transfers and more single embryo transfers were performed. As a result of this trend, ART triplets have fallen below 1%, and, for the first time, the twin delivery rate was below 20% (19.6%)."
###
Additional comments on the global estimate of 5 million babies
"Five million babies are a clear demonstration that IVF and ICSI are now an essential part of normalised and standardised clinical therapies for the treatment of infertile couples. Many aspects have changed since the early days of IVF, especially the results in terms of babies born, but there is still room for improvement. Our objective is the birth of single healthy baby and this can be achieved though the optimisation of both clinical and embryological performance."
Dr Anna Veiga, Chairman of ESHRE, and Scientific Director, Dexeus University Institute, Barcelona
"I remember well the time of Louise's birth, and also transferring the embryo that became her sister – both of whom are now mums in their own right. The 5 million milestone not only justifies all the legal and moral battles, the ethical debates and hard-fought social approval, it is also a testament to the great scientists and doctors who have worked so hard to improve the treatment of patients, and to the patients themselves who have put their faith in us. It is a moment of pride for our unique branch of medical science, and a point to reflect on how we must continue to fight for our patients where there still remain barriers to treatment."
Dr Simon Fishel, Managing Director CARE Fertility, UK, and a member of the Edwards and Steptoe group in Cambridge responsible for the birth of Louise Brown
"With ICSI now responsible for more fertilisations than conventional IVF, it seems reasonable to suppose that a good proportion of these 5 million babies will have been conceived by ICSI. When we developed the technique 20 years ago we could never have imagined that its success would be so great, nor that the world would welcome so many babies in such a short time. At 5 million babies and counting, I think we can now fairly say that the vast majority of fertility problems - whether of male or female origin - can be successfully and safely treated by IVF or ICSI."
Professor André Van Steirteghem, who with the VUB Brussels group pioneered the development of ICSI as a successful treatment for male infertility and reported the first birth in 1992.
Note: When obtaining outside comment, journalists are requested to ensure that their contacts are aware of the embargo on this release.
The 28th Annual Meeting of ESHRE, the world's largest event in reproductive science and medicine, is taking place in Istanbul from 1-4 July 2012
The world's number of IVF and ICSI babies has now reached a calculated total of 5 million
2012-07-02
ELSE PRESS RELEASES FROM THIS DATE:
Physics confirms sprinters are performing better than ever before
2012-07-02
In this month's Physics World, Steve Haake, director of the Centre for Sports Engineering at Sheffield Hallam University in the UK, reveals that the men's 100 m sprint will be one event not to miss this summer.
Haake has developed something called the "performance-improvement index", which uses very simple physics to compare the relative improvement of top athletes in different sports over the last 100 years.
The model shows that the performance-improvement index in the men's 100 m sprint is increasing at a time when those of other events, such as javelin and swimming, ...
An error-eliminating fix overcomes big problem in '3rd-gen' genome sequencing
2012-07-02
Cold Spring Harbor, NY – The next "next-gen" technology in genome sequencing has gotten a major boost.
A quantitative biologist at Cold Spring Harbor Laboratory (CSHL) and collaborators today published results of experiments that demonstrate the power of so-called single-molecule sequencing, which was recently introduced but whose use has so far been limited by technical issues.
The team, led by CSHL Assistant Professor Michael Schatz and Adam Phillippy and Sergey Koren of the National Biodefense Analysis and Countermeasures Center and the University of Maryland ...
Beyond base pairs: Mapping the functional genome
2012-07-02
Popularly dubbed "the book of life," the human genome is extraordinarily difficult to read. But without full knowledge of its grammar and syntax, the genome's 2.9 billion base-pairs of adenine and thymine, cytosine and guanine provide limited insights into humanity's underlying genetics.
In a paper published in the July 1, 2012 issue of the journal Nature, researchers at the Ludwig Institute for Cancer Research and the University of California, San Diego School of Medicine open the book further, mapping for the first time a significant portion of the functional sequences ...
Rising heat at the beach threatens largest sea turtles, climate change models show
2012-07-02
PHILADELPHIA (July 1, 2012)—For eastern Pacific populations of leatherback turtles, the 21st century could be the last. New research suggests that climate change could exacerbate existing threats and nearly wipe out the population. Deaths of turtle eggs and hatchlings in nests buried at hotter, drier beaches are the leading projected cause of the potential climate-related decline, according to a new study in the journal Nature Climate Change by a research team from Drexel University, Princeton University, other institutions and government agencies.
Leatherbacks, the largest ...
Why chronic pain is all in your head
2012-07-02
CHICAGO --- When people have similar injuries, why do some end up with chronic pain while others recover and are pain free? The first longitudinal brain imaging study to track participants with a new back injury has found the chronic pain is all in their heads –- quite literally.
A new Northwestern Medicine study shows for the first time that chronic pain develops the more two sections of the brain --- related to emotional and motivational behavior --- talk to each other. The more they communicate, the greater the chance a patient will develop chronic pain.
The finding ...
Scripps Research Institute Scientists Develop Alternative to Gene Therapy
2012-07-02
LA JOLLA, CA – July 1, 2012 – Scientists at The Scripps Research Institute have discovered a surprisingly simple and safe method to disrupt specific genes within cells. The scientists highlighted the medical potential of the new technique by demonstrating its use as a safer alternative to an experimental gene therapy against HIV infection.
"We showed that we can modify the genomes of cells without the troubles that have long been linked to traditional gene therapy techniques," said the study's senior author Carlos F. Barbas III, who is the Janet and Keith Kellogg II Professor ...
Pitt researchers propose new spin on old method to develop more efficient electronics
2012-07-02
PITTSBURGH—With the advent of semiconductor transistors—invented in 1947 as a replacement for bulky and inefficient vacuum tubes—has come the consistent demand for faster, more energy-efficient technologies. To fill this need, researchers at the University of Pittsburgh are proposing a new spin on an old method: a switch from the use of silicon electronics back to vacuums as a medium for electron transport—exhibiting a significant paradigm shift in electronics. Their findings were published online in Nature Nanotechnology July 1.
For the past 40 years, the number of transistors ...
Chronic inflammation in the brain leads the way to Alzheimer's disease
2012-07-02
Research published today in Biomed Central's open access journal Journal of Neuroinflammation suggests that chronic inflammation can predispose the brain to develop Alzheimer's disease.
To date it has been difficult to pin down the role of inflammation in Alzheimer's disease (AD), especially because trials of NSAIDs appeared to have conflicting results. Although the ADAPT (The Alzheimer`s Disease Anti-inflammatory Prevention Trial) trial was stopped early, recent results suggest that NSAIDs can help people with early stages of AD but that prolonged treatment is necessary ...
Ants farm root aphid clones in subterranean rooms
2012-07-02
The yellow meadow ant, Lasius flavus, farms root aphids for sugar (honeydew) and nitrogen (protein). In turn these species of aphids have developed distinctive traits never found in free living species such as the 'trophobiotic organ' to hold honey dew for the ants. New research published in BioMed Central's open access journal BMC Evolutionary Biology shows that over half of ant mounds contained only one of the three most common species of aphid, and two thirds of these has a single aphid clone. Even in mounds which contained more than one species of aphid 95% of the ...
Penn researchers improve living tissues with 3-D printed vascular networks made from sugar
2012-07-02
PHILADELPHIA — Researchers are hopeful that new advances in tissue engineering and regenerative medicine could one day make a replacement liver from a patient's own cells, or animal muscle tissue that could be cut into steaks without ever being inside a cow. Bioengineers can already make 2D structures out of many kinds of tissue, but one of the major roadblocks to making the jump to 3D is keeping the cells within large structures from suffocating; organs have complicated 3D blood vessel networks that are still impossible to recreate in the laboratory.
Now, University ...